New drug offers hope for dialysis Patients' relentless itching
NCT ID NCT03802617
First seen Jan 03, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This study tested a drug called MR13A9 for people on dialysis who suffer from severe itching. 247 Japanese adults participated, and the drug was compared to a placebo to see if it safely reduces itch intensity. The goal was to find the right dose and confirm the drug's effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UREMIC PRURITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.